Cidara Therapeutics Inc banner

Cidara Therapeutics Inc
NASDAQ:CDTX

Watchlist Manager
Cidara Therapeutics Inc Logo
Cidara Therapeutics Inc
NASDAQ:CDTX
Watchlist
Price: 221.38 USD Market Closed
Market Cap: $7B

Wall St Price Targets

CDTX Price Targets Summary
Cidara Therapeutics Inc

There are no price targets for CDTX.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Cidara Therapeutics Inc Competitors:
Price Targets
USEG
US Energy Corp
153% Upside
TELA
TELA Bio Inc
144% Upside

Revenue
Forecast

N/A
Past Growth
318% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
318% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Revenue over the next 4 years is 318%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Cidara Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Cidara Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CDTX's stock price target?
Not Available

CDTX does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Cidara Therapeutics Inc?
Projected CAGR
318%

The compound annual growth rate for Revenue over the next 4 years is 318%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett